Alpharma (ALO) got a $210 million senior-secured credit facility with Bank of America.

The credit line comprises a $175 million asset-based loan and a $35 million term loan, both payable in 2010. It replaces a 2001 credit facility and provides the Fort Lee, N.J., drug company with increased financial flexibility.

As a result of this refinancing, the company is no longer required to reduce the balance of its 3% senior-subordinated notes due 2006 to $10 million by Dec. 1, 2005, as was required by covenants included in the 2001 bank credit facility.

On Thursday, Alpharma fell 57 cents to $24.44.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says